Product

DAOIB+Omega-3

1 clinical trial

2 indications

Indication
Dementia
Clinical trial
NMDA Enhancement Combined With Omega-3 Fatty Acids for the Treatment of Early Dementia
Status: Not yet recruiting, Estimated PCD: 2027-06-01